Denali Therapeutics Inc. Share Price
NASDAQ: DNLI | Mid CapDenali Therapeutics Inc. Stock Performance
Denali Therapeutics Inc. Share Price Today
As of 30 October 2026, Denali Therapeutics Inc.'s share price is $19.33. The stock opened at $19.52, compared to its previous close of $19.27. During today's trading session, Denali Therapeutics Inc.'s share price traded between $19.14 and $19.68, with an average price of $19.41. Over the past 52 weeks, the stock has recorded a high of $27.27 and a low of $14.02. In terms of performance, Denali Therapeutics Inc.'s share price has risen by 3.37% over the last six months and is up 18.73% on a year-on-year basis.
Denali Therapeutics Inc. Share Price Chart
Denali Therapeutics Inc. Quarterly Profit & Loss
All figures in USD
Denali Therapeutics Inc. Annual Profit & Loss
All figures in USD
About Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Denali Therapeutics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $20.57 | $19.34 | -6.71% |
Sep 2026 | $23.59 | $20.73 | -15.97% |
Aug 2026 | $22.80 | $24.66 | +7.19% |
Jul 2026 | $25.83 | $23.01 | -10.54% |
Jun 2026 | $20.86 | $25.72 | +22.30% |
May 2026 | $18.53 | $21.03 | +12.46% |
Apr 2026 | $19.57 | $18.70 | -2.50% |
Mar 2026 | $21.07 | $19.18 | -9.46% |
Feb 2026 | $21.27 | $21.18 | -2.69% |
Jan 2026 | $16.57 | $21.77 | +31.86% |
Dec 2025 | $19.13 | $16.51 | -15.20% |
Nov 2025 | $16.12 | $19.47 | +19.59% |